Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematological malignancies

M K Brenner1

  • 1Cell and Gene Therapy Program, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A whole blood model of thrombocytopenia that controls platelet count and hematocrit.

Annals of hematology·2016
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same author

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Bone marrow transplantation·2014
Same author

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Bone marrow transplantation·2013
Same author

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

Gene therapy·2013
Same journal

Sinomenine Regulates the TRIM32/IRF1/TRAF6 Axis to Inhibit Pyroptosis in Atopic Dermatitis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β-Catenin Signaling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

MiR-124 Inhibits Lipid Deposition in Mouse Liver by Targeting the Trib3/Hnf4α Pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

TCN2 Drives Psoriasis-Like Inflammation and Keratinocyte Hyperproliferation, Correlating With IL-1β and STAT3 Activation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

The Synthetic Melanocortin Agonist NDP-MSH Ameliorates THSD7A-Associated Membranous Nephropathy in an Active Immunization Mouse Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Brain-Derived Neurotrophic Factor and Associated Signaling in Kidney Diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
See all related articles

Gene therapy offers promising new avenues for treating leukemia and lymphoma, aiming to improve efficacy and reduce toxicity compared to current cancer therapies.

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Leukemia and lymphoma treatments have improved but remain toxic and ineffective for some patients.
  • Gene therapy presents a potential alternative for these hematologic malignancies.

Purpose of the Study:

  • To explore the current strategies and limitations of gene therapy for leukemia and lymphoma.
  • To assess the potential of gene therapy in improving cancer treatment outcomes.

Main Methods:

  • Review of four major gene therapy strategies: tumor cell modification, immune response modulation, normal tissue protection, and cell marking.
  • Analysis of the successes and limitations of each approach in the context of current scientific understanding.

Main Results:

Related Experiment Videos

  • Gene therapy strategies include modifying tumor cells, enhancing anti-tumor immunity, protecting normal tissues, and monitoring treatment efficacy.
  • Each strategy has demonstrated successes but also faces significant limitations.

Conclusions:

  • Despite current limitations, gene therapy approaches show promise for future clinical applications in leukemia and lymphoma treatment.
  • Further research and development are encouraged to overcome existing challenges and realize the full potential of gene therapy.